- RecruitingPHASE3
A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.
This study looks at a special type of strong radiation, called SABR, for people with a few small cancer spots that have spread, along with a main tumor. It compares SABR plus usual care to just usual care to see if it helps.
For: Metastatic TumorCanada · Switzerland - RecruitingPHASE2
Immunochemotherapy, Surgery or Chemoradiation, and Durvalumab for Stage IIIA/B NSCLC
This study is testing if a new combination of treatments, including chemotherapy, immunotherapy, and surgery or radiation, can improve outcomes for people with certain types of advanced lung cancer. It aims to see if patients live longer without their cancer returning.
For: Lung Cancer Non-Small Cell Cancer (NSCLC)Germany - Active not recruitingPHASE3
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors
This study looks at a special type of radiation (SABR) for people with cancer that has spread a little (4-10 spots). It compares SABR to usual treatments to see if it helps people live longer, keeps cancer away, and improves their quality of life.
For: Metastatic TumorsAustralia · Canada · Netherlands